U937 cells deprived of endogenous annexin 1 demonstrate an increased PLA2 activity

British Journal of Pharmacology

Volumn 124, Issue 8, 1998, Pages 1675-1683

  Solito, Egle ^a   Raguenes Nicol, Celine ^a   De Coupade, Catherine ^a   Bisagni Faure, Anne ^a   Russo Marie, Françoise ^a  

^a INSTITUT COCHIN   (France)

Author keywords

Annexin; Cytosolic phospholipase A2; Inflammation; Secretory phospholipase A2

Indexed keywords

COMPLEMENTARY DNA; FLUORESCENT DYE; LIPOCORTIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; PRIORITY JOURNAL;

ANNEXIN A1; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CYTOSOL; ENZYME INHIBITORS; FLOW CYTOMETRY; FLUORESCENT DYES; HUMANS; INDICATORS AND REAGENTS; LIPOPOLYSACCHARIDES; PHOSPHOLIPASES A; RNA, MESSENGER; TETRADECANOYLPHORBOL ACETATE; U937 CELLS;

EID: 0031845457     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701991     Document Type: Article

References (40)

1. AMBROSETTI, D.-C., PALLA, E., MIRTELLA, A., GALEOTTI, C., SOLITO, E., NAVARRA, P., PARENTE, L. & MELLI, M. (1996). Distinct functional sites account for the diversity of IL1 β functions. Eur. J. Biochem., 238, 308-316.
2. AUSUBEL, F.M., BRENT, R., KINGSTON, R., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A. & STRUHL, K. (1995). Current Protocols in Molecular Biology, eds. John Wiley & Sons, Inc.
3. BALSINDE, J., BARBOUR, S.E., BIANCO, I.D. & DENNIS, E.A. (1994). Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in p388D1 macrophages. Proc. Natl. Acad. Sci, U.S.A., 91, 11060-11064.
4. BALSINDE, J. & DENNIS, E.A. (1996). Distinct roles in signal transduction for each of the phospholipase A2 enzymes in P388D1 macrophages. J. Biol. Chem., 271, 6758-6765.
5. BECHERUCCI, C., PERRETTI, M., SOLITO, E., GALEOTTI, C.L. & PARENTE, L. (1993). Conceivable difference in the anti-inflammatory mechanisms of lipocortin 1 and 5. Med. Inflam., 2, 109-113.
6. CIRINO, G., PEERS, S., FLOWER, R., BROWNING, J. & PEPINSKY, R. (1989). Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. Proc. Natl. Acad. Sci, U.S.A., 86, 3428-3432.
7. COMERA, C., ROTHHUT, B. & RUSSO-MARIE, F. (1990). Identification and characterization of phospholipase A2 inhibitory proteins in human mononuclear cells. Eur. J. Biochem., 188, 139-146.
8. CROXTALL, J.D., CHOUDHURY, Q., NEWMAN, S. & FLOWER, R.J. (1996). Lipocortin 1 and the control of cPLA2 activity in A549 cells. Biochem. Pharmacol., 52, 351-356.
9. CROXTALL, J.D., CHOUDHURY, Q., TOKUMOTO, H. & FLOWER, R.J. (1995). Lipocortin-1 and the control of arachidonie acid release in cell signalling. Biochem. Pharmacol., 50, 465-474.
10. DAVIDSON, F., DENNIS, E. & POWELL, M. (1987). Inhibition of phospholipase A2 by lipocortins and calpactins-an effect of binding to substrate phospholipid. J. Biol. Chem., 262, 1698-1705.
11. DAVIDSON, J., FLOWER, R., MILTON, A., PEERS, S. & ROTONDO, D. (1991). Antipyretic actions of human recombinant lipocortin-1. Br. J. Pharmacol., 102, 7-9.
12. 2 superfamily of signal transduction enzymes. Trends Biochem., 22, 1-2.
13. ERRASFA, M. & RUSSO-MARIE, F. (1989). A purified lipocortin shares the anti-inflammatory effect of glucocorticosteroids in vivo in mice. Br. J. Pharmacol., 97, 1051-1058.
14. 2 generates the Novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell, 80, 919-927.
15. HAYASHI, J., LIU, P., FERGUSON, S.E., WEN, M., SAKATA, T., TERAOKA, H. & DRINKER RILEY III, H. (1993). Arachidonie Acid metabolism in cells transfected with sense and anti-sense cDNA to annexin I. Biochem. Molec. Biol. Intern., 31, 143-151.
16. HIRATA, F., MATSUDA, K., NOTSU, Y., HATTORI, T. & DEL CARMINE, R. (1984). Phosphorylation at a tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytes. Proc. Natl. Acad. Sci. U.S.A., 81, 4717-4721.
17. HIRATA, F., NOTSU, Y., IWATA, M., PARENTE, L., DI ROSA, M. & FLOWER, R. (1982). Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. Biochem. Biophys. Res. Commun., 109, 223-230.
18. 2 by specific interaction, not by substrate depletion. FEBS Lett., 343, 251-255.
19. 2. J. Biol. Chem., 264, 5768-5775.
20. 2 is a 100-kDa protein in human monoblast U 937 cells. J. Biol. Chem., 266, 5268-5272.
21. LAEMMLI, U. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
22. 2 does not alter leukotriene formation. J. Biol. Chem., 272, 759-765.
23. MARSHALL, L.A. & RSHAK, A, (1993). Coexistence of two biochemically distinct phospholipase A2 activities in human platelets, monocyte, and neutrophil. Biochem. Cell Biol., 71, 331-339.
24. MESHULAM, T., HERSCOVITZ, H., CASAVANT, D., BERNARDO, J., ROMAN, R., HAUGLAND, R.P. STROHMEIER, G.S., DIAMOND, R.D. & SIMONS, E.R. (1992). Flow cytometric kinetic measurements of neutrophil phospholipase A activation. J. Biol. Chem., 267, 21465-21470.
25. NOLAN, G.P., FIERING, S., NICOLAS, J-F., HERZENBERG, L.A. (1988). Fluorescence-activated cell analysis and sorting of viable mammalian cells based on β-D-galactosidase activity after transduction of Escherichia coli lac Z. Proc. Natl. Acad. Sci. U.S.A., 85, 2603-2607.
26. PEPINSKY, R.B. (1991). Phosphorylation of lipocortin-1 by the epidermal growth factor receptor. Meth. Enzymol., 198, 260-272.
27. PERRETTI, M. & FLOWER, R.J. (1993). Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J. Immunol., 150, 992-999.
28. 2. J. Biol. Chem., 269, 19480-19487.
29. ROBERTS, M. (1996). Phospholipases: structural and functional motifs for working at an interface. FASEB J., 10, 1159-1172.
30. 2 and the glucocorticoids In Annexins, (ed) S.E. Moss, pp 35-46. Portland Press Research Monograph.
31. SAMBROOK, J., FRITSCH, E.F. & MANIATIS, T. (1989). Molecular cloning. A laboratory manual. Cold Spring Harbour Laboratory Press, New York 2nd Edition.
32. SKOUTERIS, G. & SCHRODER, C. (1996). The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor. J. Biol. Chem., 271, 27266-27273.
33. SLEIGHT, R.G. & PAGANO, R.E. (1984). Transport of a fluorescent phosphatidylcholine analog from the plasma membrane to the Golgi apparatus. J. Cell Biol., 99, 742-751.
34. SOLITO, E., DE COUPADE, C., PARENTE, L., FLOWER, R. & RUSSO MARIE, F. (1998a). IL-6 stimulates Annexin 1 expression and translocation and suggests a new biological role as class II acute phase protein. Cytokine, in press.
35. SOLITO, E., DE COUPADE, C., PARENTE, L., FLOWER, R. & RUSSO-MARIE, F. (1998b). Human annexin 1 is highly expressed during the differentiation of the epithelial cell line A 549 involvment of NFIL-6 in Phorbol Ester Induction of Annexin 1. Cell Growth and Differentiation, 9, 327-336.
36. SOLITO, E., NUTI, S. & PARENTE, L. (1994). Dexamethasone-induced translocation of lipocortin (annexin) 1 to the cell membrane of U-937 cells. Br. J. Pharmacol., 112, 347-348.
37. SOLITO, E., RAUGEI, G., MELLI, M. & PARENTE, L. (1991). Dexamethasone induces the expression of the mRNA of lipocortin 1 and 2 and the release of lipocortin 1 and 5 in differentiated, but not undifferentiated U-937 cells. FEBS Lett., 291, 238-244.
38. 2. Biochemistry, 32, 5935-5940.
39. 2 expression and inflammation: the relationship with associated disease states. J. Lipid Med., 8, 1-30.
40. VAN DEN BOSCH, H. (1980). Intracellular phospholipases A. Biochim. Biophys. Acta, 604, 191-246.